Arrowhead Reports Fiscal 2016 First Quarter Results

Go back to Arrowhead Reports Fiscal 2016 First Quarter Results

Arrowhead Research (ARWR) Ends 1Q with $77M to Focus on HBV and AAT; Piper Jaffray Reiterates Overweight

February 10, 2016 9:21 AM UTC

Piper Jaffray maintained an Overweight rating on Arrowhead Research (NASDAQ: ARWR), and cut the price target to $13.00 (from $20.00), following the company's 1Q earnings report. Arrowhead ended 1Q with cash and equivalents of $77 million. The company began enrolling the first 6 cohorts of the open-label, adaptive... More

Arrowhead Research (ARWR) Tops Q2 EPS by 9c

February 9, 2016 4:47 PM UTC

Arrowhead Research (NASDAQ: ARWR) reported Q2 EPS of ($0.32), $0.09 better than the analyst estimate of ($0.41).

For earnings history and earnings-related data on Arrowhead Research (ARWR) click here.

... More